March 10-13, 2016 - Amazon S3...March 10-13, 2016 FONTAINEBLEAU MIAMI BEACH MIAMI BEACH, FL Register...

March 10-13, 2016FONTAINEBLEAU MIAMI BEACHMIAMI BEACH, FL

Register early and save! Register by February 29th and save $125 off the price of registration. Enter code M16BR2*

*Discount available for physicians only

ChairPatrick I. Borgen, MDChairman, Department of Surgery Maimonides Hospital Director, Brooklyn Breast Cancer Program Brooklyn, NY

Program DirectorsJ. Michael Dixon, MDHyman B. Muss, MDDebu Tripathy, MD

30.0 AMA PRA Category 1 Credits™/

Contact Hours available!

Now Approved for Nursing Continuing Education! Earn up to 30.0 Contact Hours!

OverviewThe overriding theme of the Miami Breast Cancer Conference®, “Hear it on Friday, use it on Monday”, continues to be embraced by the Chairs of the conference. Indeed, at the 33rd Annual Miami Breast Cancer Conference®, attendees will not only improve their knowledge of novel treatment approaches, but also leave the conference with the confidence and intent to apply state-of-the-art treatment strategies to care for their patients with breast cancer.

The multidisciplinary Miami Breast Cancer Conference® has a tremendous legacy to bring together key disciplines from medical, surgical, and radiation oncology, as both faculty and attendees. International experts continue to serve as faculty for this premier and internationally renowned oncology conference, which focuses on the most relevant breast cancer topics during General Sessions, Medical and Surgical Tracked Sessions, Tumor Boards, and the popular Medical Crossfire® Sessions.

Target AudienceThis educational program is directed toward medical, surgical, and radiation oncologists interested in the treatment of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, researchers, and other health care professionals interested in the treatment of breast cancer are also invited to attend.

Accreditation/Designation of Credit InformationPhysicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 30.0 Contact Hours. Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 30.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.This activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org/default.jsp?exam-moccme

Acknowledgment of Commercial SupportThis activity is supported by educational grants from Astellas, AstraZeneca, Celgene, Eisai Inc., Genentech, Inc., Genomic Health, Inc., Lilly, Novartis Pharmaceuticals Corporation, Pfizer, and TESARO, Inc.For further information concerning Lilly grant funding visit www.lillygrantoffice.com.

Mini-SymposiumThe 33rd Annual Miami Breast Cancer Conference® Mini-Symposium offers an additional educational opportunity for attendees who plan to arrive in Miami the day before the official conference begins. The Mini-Symposium takes the format of a World-Class Tumor Board, featuring cases and discussions that highlight challenging clinical situations commonly faced by surgeons and oncologists, including:

• The value of excision when LCIS is found at core needle biopsy

• Breast-conservation therapy by tumor biologic subtype

• The challenge of pain management• Defining and managing invasive

lobular carcinoma• Regional node irradiation in sentinel

node-positive disease• Contemporary issues in

lymphedema• Therapy for intermediate-risk ER-

positive, HER2-negative tumors• And more...

This special session was developed to be of interest to healthcare practitioners from all specialties and will provide practical information to enhance patient care in the clinic, delivered by top experts in the field of breast cancer. If your schedule allows, we hope you will plan to attend and take advantage of this extra session! Separate registration is required.

Program ChairPatrick I. Borgen, MDChairman, Department of SurgeryMaimonides HospitalDirector, Brooklyn Breast Cancer Program

Brooklyn, NY

Program Directors

Faculty

Register early and save!

Register by February 29th and save $125 off the price of registration. Enter code M16BR2*


Banu Arun, MDProfessor, Department of Breast Medical Oncology

Co-Medical Director, Clinical Cancer Genetics Program

MD Anderson Cancer CenterHouston, TXKimberly Blackwell, MDProfessor of MedicineAssistant Professor of Radiation Oncology

Duke University Medical CenterDurham, NCJudy C. Boughey, MDProfessor of SurgeryBreast Diagnostic ClinicCancer Care at Mayo ClinicRochester, MNAnees B. Chagpar, MD, MSc, MBA, MA, MPH, FACS, FRCS

Associate Professor of Surgery (Oncology)

Director, The Breast Center at Smilow Cancer Hospital at Yale-New Haven

Assistant Director, Global OncologyYale Comprehensive Cancer CenterNew Haven, CTMatthew Ellis, MD, PhDDirector of the Lester and Sue Smith Breast Center

Professor of Medicine and Cellular and Molecular Biology

Baylor College of MedicineHouston, TXKevin Hughes, MDCo-Director, Avon Comprehensive Breast Evaluation Center

Medical Director, Bermuda Cancer Genetics and Risk Assessment Clinic

Massachusetts General HospitalBoston, MA

Henry Kuerer, MD, PhD, FACS, CMQProfessor of Surgery and DirectorBreast Surgical Oncology Training Program

Medical Director, Clinical ExpansionThe University of Texas MD Anderson Cancer Center

Houston, TXConstance Lehman, MD, PhDMedical Director, Imaging, Seattle Cancer Care Alliance

Professor and Vice Chair, Radiology Department

University of Washington School of Medicine

Joint Member, Public Health Sciences Division

Fred Hutchinson Cancer Research Center

Seattle, WADouglas Macmillan, MB ChB, MD, FRCS

Consultant Oncoplastic Breast SurgeonNottingham City HospitalNottingham Breast InstituteNottingham, UKDonna-Marie Manasseh, MDDirector of Breast SurgeryMaimonides Breast Cancer CenterBrooklyn, NY

Maurie Markman, MDPresident, Medicine and ScienceCancer Treatment Centers of AmericaPhiladelphia, PAElizabeth Mittendorf, MD, PhDAssociate Professor and Deputy Chair for Research

Department of Surgical OncologyThe University of Texas MD Anderson Cancer Center

Houston, TXJoyce O’Shaughnessy, MDCo-Director, Breast Cancer ResearchBaylor Charles A. Sammons Cancer Center

Texas OncologyThe US Oncology NetworkDallas, TXAnn H. Partridge, MD, MPHFounder and DirectorProgram for Young Women with Breast Cancer

Director, Adult Survivorship ProgramSenior Physician, Dana-Farber Cancer Institute

Associate Professor of Medicine, Harvard Medical School

Boston, MA

J. Michael Dixon, MDOBE Professor of Surgery and Consultant Surgeon

Clinical Director, Breakthrough Research Unit

Edinburgh Breast UnitEdinburgh, UK

Hyman B. Muss, MD Professor of OncologyUniversity of North Carolina

Director of Geriatric Oncology

Lineberger Comprehensive Cancer Center

Chapel Hill, NC

Debu Tripathy, MDProfessor of Medicine and Chair

Department of Breast Medical Oncology

The University of Texas MD Anderson Cancer Center

Houston, TX

Friday, March 11, 20167:00 am Breakfast

7:50 am Welcome and Pre-Session Survey Patrick I. Borgen, MD

8:00 am Immunotherapy Update: Biology and Early Results: VACCINES Elizabeth Mittendorf, MD

8:30 am Defining Best End Results for Drug Development: Common Sense Maurie Markman, MD

8:45 am What Is the Current Definition of Clear Margin in DCIS? Kimberly Van Zee, MD, FACS

9:00 am Cases/ARS

9:15 am Is Chemoprevention Dead? Banu Arun, MD

9:30 am Where Are We With Extended Whole-Breast Radiation? Timothy Whelan, MD, BSc, BM BCh, MSc

9:45 am International Guidelines for Pathologic Response Assessment After Neoadjuvant Treatment W. Fraser Symmans, MD

10:00 am BREAK

10:30 am MEDICAL CROSSFIRE®: INTEGRATING CDK4/6 INHIBITORS INTO THE MANAGEMENT OF BREAST CANCERS Moderator: Hyman B. Muss, MD

10:30 am Point Pro: Matthew Ellis, MD, PhD

10:45 am Counterpoint Con: Debu Tripathy, MD

11:15 am New Developments in Adjuvant Endocrine Therapy in Premenopausal Patients Kimberly Blackwell, MD

11:30 am Should Intrinsic Subtypes Guide Cancer Therapy? Charles Perou, PhD

11:45 am Impact of Neoadjuvant Endocrine Therapy on Breast Conservation Candidacy Judy C. Boughey, MD

12:00 pm Computer-Based Physician Support in Breast Cancer Decision Making. The Time Is Now! Andrew Seidman, MD

12:15 pm Post-Session Survey

12:20 pm Panel Discussion

12:45 pm LUNCH

2:00 pm - 6:00 pm — Breakout Sessions (see agendas below)

SURGICAL ONCOLOGY TRACK2:00 pm Pre-Session Survey2:05 pm Breast Cancer Risk Estimate in the Era of

Density Legislation Kevin Hughes, MD

2:20 pm Treatment vs Observation in DCIS Henry Kuerer, MD, PhD, FACS, CMQ

2:35 pm How Does Age Impact Outcome in DCIS? Kimberly Van Zee, MD, FACS2:50 pm Current Indications for Post-Mastectomy

RadiationTimothy Whelan, MD, BSc, BM BCh, MSc

3:05 pm Rational Use of MRI in Routine Clinical Practice Constance Lehman, MD, PhD3:20 pm Male Cancer J. Michael Dixon, OBE, MD3:35 pm Male Breast Cancer Cases and Panel J. Michael Dixon, MD;

Patrick I. Borgen, MD; Timothy Whelan, MD, BSc, BM BCh, MSc; Andrew Seidman, MD

3:50 pm BREAK4:20 pm OncoCosmetic Surgery and Breast Cancer Douglas Macmillan, MB

ChB, MD, FRCS

4:35 pm Challenging Cases

4:50 pm Enchanced Recovery After Breast Surgery: Opioid-Sparing Approaches

Donna-Marie Manasseh, MD

5:05 pm The Never-Ending Controversy Surrounding Mammographic Screening

Constance Lehman, MD, PhD

5:20 pm TBA


5:40 pm PANEL DISCUSSION All Faculty

6:00 pm Adjourn

6:00 pm Get Acquainted Reception (Exhibit Hall)

MEDICAL ONCOLOGY TRACK2:00 pm Pre-Session Survey

2:05 pm Treatment Adherance in Young Women on Endocrine Blockade

Ann H. Partridge, MD, MPH

2:20 pm HER2 Status Determination: Best Practices - FISH, SISH, RT-PCR

W. Fraser Symmans, MD

2:35 pm State-of-the-Art Therapy in HER2-Positive, Early-Stage Breast Cancer

Kimberly Blackwell, MD

2:50 pm Update on the Emerging Story of Estrogen Receptor Mutations

Matthew Ellis, MD, PhD


3:35 pm BREAK

4:05 pm Immunotherapy Using Checkpoint Inhibitors Elizabeth Mittendorf, MD, PhD

4:20 pm Genetic Susceptibility Panels: Update Banu Arun, MD

4:35 pm Fertility Preservation in the Young Breast Cancer Patient

Ann H. Partridge, MD, MPH

4:50 pm Update on the Moonshot Trial for TNBC W. Fraser Symmans, MD

5:05 pm Adjuvant Chemotherapy: Risk-Adjusted or One Size Fits All?

Andrew Seidman, MD



5:45 pm ADJOURN

6:00 pm — Get Acquainted Reception (Exhibit Hall)

World Class Tumor Boardseperate registration required

MORNING TRACK - GENERAL SESSION

12:50 pm Welcome and Pre-Session Survey Patrick I. Borgen, MD1:00 pm Cases/ARS1:20 pm BCT vs Mastectomy: Is It Time to Stop Giving Patients a Choice?1:20 pm Point J. Michael Dixon, MD1:35 pm Counterpoint Patrick I. Borgen, MD1:50 pm Cases/ARS2:00 pm Is It Time To Stop Removing Borderline Epithelial Lesions Identified on

Core Biopsy? W. Fraser Symmans, MD2:15 pm Cases/ARS2:20 pm Predicting Outcome in DCIS: MSKCC Nomogram Kimberly Van Zee, MD, FACS2:35 pm Cases/ARS2:45 pm Timing of Risk-Reducing BSO in BRCA Heterozygotes Maurie Markman, MD3:00 pm Cases/ARS3:05 pm Contralateral Risk-Reducing Mastectomy - Pros and Cons

Anees Chagpar, MD, MSc, MBA, MA, MPH, FACS, FRCS3:20 pm BREAK3:40 pm Cases/ARS3:45 pm What Is the Role of Radiation Therapy in the Elderly Patient Undergoing

BCS? Kevin Hughes, MD

4:00 pm Cases/ARS4:05 pm To Radiate or Not? Is APBI the Right Compromise Solution? Julia White, MD4:20 pm Cases/ARS4:25 pm Is Your Breast Center NAPBC Accredited? Should It Be?

Donna-Marie Manasseh, MD4:40 pm Cases/ARS4:45 pm Biomarker-Driven Decision-Making for Hormone Responsive Breast Cancer

Matthew Ellis, MD, PhD5:00 pm Cases/ARS5:05 pm Controversies in the Young Breast Cancer Patient: Preimplantation

Genetic Diagnosis and Others Ann H. Partridge, MD, MPH5:20 pm Cases/ARS5:25 pm Use of Carboplatin in Triple-Negative Breast Cancer

Gunter von Minckwitz, MD, PhD5:40 pm Post-Session Survey5:45 pm Panel Discussion6:30 pm Adjourn6:30 pm Welcome Reception (Exhibit Hall)7:15 pm POSTER DISCUSSION (Luster Gallerie)

Thursday, March 10, 2016 — Mini-Symposium Moderator: Patrick I. Borgen, MD

Saturday, March 12, 2016 7:00 am Breakfast Satellite Session: Medical Crossfire®: Integrating CDK4/6 Inhibitors into the Management of Breast Cancers

8:00 am Breakfast

8:50 am Welcome and Pre-Session Survey

9:00 am Neoadjuvant Platform for Drug Approvals - Are We Ready? Gunter von Minckwitz, MD, PhD

9:15 am Novel Strategies Targeting Drivers of Triple-Negative Breast Cancer Joyce O'Shaughnessy, MD

9:30 am Feasibility Trial for Eliminating Breast Cancer Surgery in Exceptional Responders Henry Kuerer, MD, PhD, FACS, CMQ

9:45 am Is Genomic Profiling of DCIS Ready for Prime Time? Patrick I. Borgen, MD

10:00 am Reimagining Oligomets: Focused Resection or SBRT? Julia White, MD

10:30 am MEDICAL CROSSFIRE® – Should All Stage II Breast Cancer Patients Receive Systemic Therapy Before Surgery? Moderator: Debu Tripathy, MD

10:15 am Point Pro: J. Michael Dixon, MD

10:30 am Counterpoint Con: Patrick I. Borgen, MD

10:45 am BREAK

11:15 am Keynote Address TBA

12:15 pm Cases/ARS

12:20 pm Neoadjuvant Therapy in HER2+ Breast Cancer Sunil Verma, MD



1:00 pm LUNCH

2:00 pm - 5:45 pm — Breakout Sessions (see agendas below)

6:00 pm - 7:30 pm — Closing Reception (Lawn)

MORNING TRACK - GENERAL SESSION

Sunday, March 13, 20167:00 am Breakfast

7:50 am Welcome and Pre-Session Survey

8:00 am Assessing Treatment Response in Metastatic Breast Cancer Hyman B. Muss, MD

8:15 am Routine Shave Margins Versus Standard Partial Mastectomy Anees Chagpar, MD, MSc, MBA, MA, MPH, FACS, FRCS

8:30 am Intraoperative Margin Assessment J. Michael Dixon, MD8:45 am TBA TBA9:00 am Cases/ARS9:15 am When Is Surgery Justified in Metastatic Breast Disease? Patrick I. Borgen, MD9:30 am Novel Technologies ("Gadgets") That Facilitate Breast Cancer Treatment Douglas Macmillan, MB ChB, MD, FRCS9:45 am Brain Metastases Andrew Seidman, MD

10:00 am Surviving in the Evolving EMR World Kevin Hughes, MD10:15 am BREAK10:45 am ASCO Update Debu Tripathy, MD, and Faculty11:00 am San Antonio Update Faculty11:15 am Cases/ARS11:30 am Post-Session Survey11:35 am PANEL DISCUSSION12:05 pm Presentation and Discussion of Cases Submitted by Audience Members12:50 pm Wrap-up/Final Remarks Patrick I. Borgen, MD1:00 pm Adjourn

SURGICAL ONCOLOGY TRACK2:00 pm Pre-Session Survey2:05 pm Axillary Management in Early Stage, Clinically

Node Negative Breast CancerElizabeth Mittendorf, MD, PhD

2:20 pm Targeted Axillary Dissection for Node-Positive Breast Cancer

Henry Kuerer, MD, PhD, FACS, CMQ

2:35 pm Management of Axilla After Neoadjuvant Chemotherapy: Node-Negative

Judy C. Boughey, MD

2:50 pm Management of Axilla After Neoadjuvant Chemotherapy: Node-Positive

Judy C. Boughey, MD

3:05 pm Tomosynthesis (3D) Mammography Update Constance Lehman, MD, PhD3:20 pm TBA TBA3:35 pm Challenging Cases

3:50 pm BREAK

4:20 pm Cases/ARS

4:25 pm Who Does Not Need RT in Conservatively Treated DCIS?

Julia White, MD

4:40 pm Comparing Oncoplastic BCS with Mastectomy and Reconstruction

Douglas Macmillan, MB ChB, MD, FRCS

4:55 pm Multisite Disease and Breast Conservation Anees Chagpar, MD, MSc, MBA, MA, MPH, FACS, FRCS

5:10 pm Localization of Nonpalpable Lesions Without Wires

Donna-Marie Manasseh, MD


5:30 pm Panel Discussion

5:50 pm ADJOURN6:00 pm Closing Reception

MEDICAL ONCOLOGY TRACK2:00 pm Pre-Session Survey

2:05 pm Lobular Breast Cancer Subtypes: Integration Into Clinical Arena

Charles Perou, PhD

2:20 pm Aromatase Inhibitors in DCIS Kimberly Blackwell, MD

2:35 pm Lessions Learned From Neoadjuvant Correlative Studies

Gunter von Minckwitz, MD, PhD

2:50 pm Advancing Treatment in ER+ HER-2 + Breast Cancer: The Next Frontier

Sunil Verma, MD

3:05 pm Breast Cancer in The Pregnant Patient Hyman B. Muss, MD

3:20 pm Options for Advanced Triple-Negative Breast Cancer

Banu Arum, MD


4:50 pm BREAK4:20 pm Cases/ARS

4:35 pm What Has Sequencing the Genome Taught Us?

Charles Perou, PhD

4:50 pm Current Standards and Novel Strategies in ER+ Metastatic Disease

Joyce O'Shaughnessy, MD

5:05 pm HER2-Targeted Therapy in Advanced Disease

Sunil Verma, MD



5:50 pm ADJOURN

6:00 pm Closing Reception

MOC for SurgeonsThis activity provides Category I CME and self-assessment credits toward Part 2 of the ABS MOC Program. For more information, please visit www.absurgery.org/default.jsp?exam-moccme.

LocationThe Fontainebleau Miami Beach Hotel is located on Collins Avenue overlooking the Atlantic Ocean, 3 miles from South Beach. It is conveniently located near both Miami and Fort Lauderdale International Airports.

Travel Arrangements We recommend that you make your reservations early to get the best seat options and lowest airfare available. Miami International Airport (MIA) is the major gateway serving the Miami area and is located approximately 12 miles from the Fontainebleau Hotel. The Fort Lauderdale International Airport (FLL) is located 28 miles from the hotel.

You are invited to make your travel arrangements by contacting PER® travel partner, Singer Travel, at (610) 378-1610 between 9:00 AM and 5:30 PM ET.

AccommodationsFontainebleau Miami Beach 4441 Collins Avenue Miami Beach, FL 33140 Reservations: (800) 548-8886

When making reservations, mention the Miami Breast Cancer Conference® to receive the discounted rate before February 29th, 2016.

For more information and registration, visit …

Charles Perou, PhDThe May Goldman Shaw Distinguished Professor of Molecular Oncology

Professor of Genetics and Pathology and Laboratory Medicine

Lineberger Comprehensive Cancer Center

UNC School of MedicineChapel Hill, NCAndrew Seidman, MDAttending Physician, Breast Cancer Medicine Service

Memorial Sloan Kettering Cancer Center

New York, NYW. Fraser Symmans, MDProfessor of PathologyDirector of Research OperationsThe University of Texas MD Anderson Cancer Center

Houston, TX

Kimberly Van Zee, MD, FACSSurgical OncologistMemorial Sloan Kettering Cancer Center

New York, NYSunil Verma, MD, MSEd, FRCPCMedical Director, Tom Baker Cancer Centre

Professor and Head, Department of Oncology

Cumming School of MedicineUniversity of CalgaryAlberta, CanadaGunter von Minckwitz, MD, PhDAssociate Professor and Senior Physician

Center of Gynecology and ObstetricsUniversity Women’s Hospital, Frankfurt, Germany

Managing Director, German Breast Group

Neu-Isenburg, Germany

Timothy Whelan, MD, BSc, BM BCh, MSc

Professor of Oncology, Department of Medicine

McMaster UniversityCanada Research Chair in Health Services Research in Cancer

Associate Member, Department of Clinical Epidemiology & Biostatistics

Director, Supportive Cancer Care Research Unit

Juravinski Cancer CentreOntario, CanadaJulia White, MDRadiation Oncologist and ProfessorStefanie Spielman Comprehensive Breast Center

The Ohio State University Comprehensive Cancer Center

Columbus, OH

Faculty (continued)

RegistrationRegistration fees for the 33rd Annual Miami Breast Cancer Conference® include breakfast, breaks, receptions, and e-syllabus materials.

4 Ways to Register1. Online: Register online at

gotoper.com

2. Fax: Please complete the registration form and fax to (609) 257-0705 (credit cards only).

3. Phone: Please call (609) 378-3701 (credit cards only).

4. Mail a completed registration form along with a check made payable to: Physicians’ Education Resource® - MBC16 666 Plainsboro Road, Suite 356 Plainsboro, NJ 08536

For registration assistance, please e-mail [email protected] or call (888) 949-0045 or (609) 378-3701.

A cancellation fee of 50% will be assessed on refunds requested through and including February 25, 2016. No refunds will be made after February 25, 2016. There is no charge for substitution.

Physicians’ Education Resource®, LLC666 Plainsboro Road, Suite 356Plainsboro, NJ 08536

Phone: (888) 949-0045Fax: (609) 257-0705

Registration Form All fields are required.First Name Middle Initial

Last Name Degree(s)

❏ Physician ❏ Fellow ❏ PA-C ❏ Nurse ❏ NP ❏ Pharmacist ❏ Other Nursing License #

Are you employed by a for-profit organization, including biotech, financial, and pharmaceutical, defined as “Industry” by PER®? ❏ Yes ❏ No

Address type ❏ Home ❏ Hospital ❏ Office

Mailing Address

City Prov/State

Country Postal/Zip Code

E-mail (Your confirmation will be sent via e-mail)

Phome type ❏ Home ❏ Mobile ❏ Work

Phone Fax

Specialty Birth Date (MM/DD/YYYY)

Institute/Organization

Payment can be made by: ❏ Check ❏ VISA ❏ MasterCard ❏ Discover ❏ American Express

Charge Amount

Card Number Expiration Date

Name as It Appears on Credit Card Security Code

Billing Address of Card (if different from above; zip code required)

Signature ______________________________________________________________________________________________

# of Guests ____________________________________________________________________________________________

First Name

Last Name

Email

All payments must be made by a draft on a United States bank.

*Discount does not apply to the Mini-Symposium or Guest Registration. **FELLOWS registration must be accompanied by a letter from your director/chair stating current fellowship for discount. Cannot be combined with other discounts/coupon codes. *** INDUSTRY is defined by PER® as any person employed by a for-profit organization, including biotech, financial,

and pharmaceutical.

Preferred educational formats:❏ Live ❏ Online ❏ Print

Preferred methods of communication:❏ Phone ❏ Mail ❏ E-mail

Practice Setting❏ Academic medical center/university ❏ Community hospital-based practice ❏ Community office-based practice

❏ In training (fellow, resident, student) ❏ Government agency ❏ Laboratory/basic research

❏ Pharmacy ❏ Pharmaceutical/biotechnology company ❏ Other

What is your principal activity?❏ Patient care ❏ Clinical research ❏ Teaching/training ❏ Administrative ❏ Other

Would you like to participate in CME surveys? ❏ Yes ❏ No

Would you like to enroll in the PER Point System? ❏ Yes ❏ No

How many breast cancer patients do you treat each month?

Years practicing medicine

MINI SYMPOSIUM* &MAIN CONFERENCE

March 10-13, 2016

MAIN CONFERENCE ONLY

March 11-13, 2016ADVANCE ON-SITE ADVANCE ON-SITE

Physicians $1,159 $1,279 $819 $869Nurses, PAs, Other HCPs $969 $1,089 $629 $679Fellows** $969 $1,089 $629 $679Industry*** $1,309 $1,429 $969 $1,019Guest (access to receptions only)* $189 $239 $189 $239

Register early and save! Register by February 29th and save $125 off the price of registration. Enter code M16BR2*


Offi

ce C

ente

r at P

rince

ton

Mea

dow

s66

6 Pl

ains

boro

Roa

d, S

uite

356

Plai

nsbo

ro, N

J 08

536

Mar

ch 1

0 – 1

3, 2

016

FON

TAIN

EBLE

AU M

IAM

I BEA

CHM

IAM

I BEA

CH, F

L

For m

ore

info

rmat

ion

and

regi

stra

tion,

visi

t …

Regi

ster

ear

ly a

nd s

ave!

Re

gist

er b

y Fe

brua

ry 2

9th

and

save

$12

5 of

f th

e pr

ice o

f reg

istra

tion.

Ent

er c

ode

M16

BR2*

*Dis

coun

t ava

ilab

le fo

r phy

sici

ans

only

March 10-13, 2016 - Amazon S3...March 10-13, 2016 FONTAINEBLEAU MIAMI BEACH MIAMI BEACH, FL Register...

Documents

Transcript of March 10-13, 2016 - Amazon S3...March 10-13, 2016 FONTAINEBLEAU MIAMI BEACH MIAMI BEACH, FL Register...